Hyang Jo Email & Phone Number

South San Francisco, California, United States

Support strategic investment decision making in early drug development for oncology assets; Valuation of assets with a goal of maximizing and unlocking value through development stages; Planning & management of development project life time finance

South San Francisco, California, United States

FRDP (Finance Rotation Development Program) 1st Rotation: Commercial Finance 2nd Rotation: gRED Finance - early R&D

South San Francisco, California, United States

FRDP (Finance Rotation Development Program) Intern

Boston, MA (remote)

Ideated on and tested product use scenarios by interviewing 25+ stakeholders to develop product value proposition, resulting in a new clinical trial opportunity at a prominent hospital in California

Budapest, Hungary

• (Operated regional business independently)
• Managed commercial operations for four products, served as lead point of contact for partnerships with the two largest EU distributors, executed $50M+ revenue reconciliations, and managed entire EU product supply
• Spearheaded a firm strategic initiative to set up sales networks in six countries by devising logistical and financial models; program was essential in growing the firm into an integrated global pharma company
• Built collaborative relationships from the ground up with physicians and advisors to ministries of health in three countries to develop communication and market access strategies, creating firm’s first advisor network.
• Revitalized trials during COVID-19 pandemic to meet time-to-market by analyzing underlying issues, mapping key trial sites, convincing doctors and hosting three investigator meetings, resulting in 2.5x patient.

U.S. And Korea

• Negotiated a product purchase worth $38M with Pfizer by conducting in-depth contract and sales projection analysis, developing negotiation strategy, and leading an ad-hoc, cross-functional team of ten, including three.
• Orchestrated 20+ cross-company functional teams in three continents for global distribution of Inflectra® by facilitating communication and instituting work processes, achieving alliance goal of cutting time to resolve.
• Saved $200K by identifying equivocal cost-sharing term and agreeing on clear execution methods with Pfizer finance

U.S., Canada, And Korea

• Led a team of four during a one-year outreach to U.S. and Canadian physicians and stakeholders to analyze value chains for biological drugs in immunology; results reported to CEO and used to create firm’s partnership.

Korea, The Czech Republic, Poland, Romania And Russia

• (Managed indirect sales under oversight)
• Directed EU launch projects by working with three distributor country teams, creating co-marketing activities to persuade stakeholders for biosimilar entry and making calls to doctors to prescribe new drug, resulting.
• Resolved a quality issue in Russia by working across seven global teams, resulting in on-time launch and $6M in sales
• Built local manufacturing models in Russia by analyzing public procurement policy, resulting in firm’s first local manufacturing case and acquisition of a 15% price advantage in state tenders that lasted two years

Master Of Business Administration - Mba

Merit-based Dean's Fellowship; Sloan Healthcare Bioinnovations Conference organizing team (21', 22') Treasurer, MIT Korean Graduate.

Bachelor Of Business Administration (Bba) & Russian Language And Literatures, Bachelor Of Arts

Activities and Societies: Elected Vice-President, Student Council; Merit-based Scholarship

Study Abroad Program, Ekaterinburg, Russia (1 Year)